Prognostic significance of ventricular late potentials in coronary artery disease

Insights

Ventricular late potentials (VLPs) are common in coronary artery disease (CAD) and significantly increase the risk of sustained ventricular tachycardia/fibrillation (VT/VF), especially in patients with ventricular aneurysm or a history of VT/VF.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Ventricular late potentials (VLPs) are potential indicators of arrhythmic risk.
  • Their prevalence and prognostic significance in coronary artery disease (CAD) require further investigation.

Purpose of the Study:

  • To determine the prevalence of VLPs in CAD patients.
  • To assess the prognostic value of VLPs for sustained ventricular tachycardia/fibrillation (VT/VF).

Main Methods:

  • High-gain electrocardiography (ECG) and signal-averaging techniques were used.
  • VLPs were assessed in 92 CAD patients, with follow-up for VT/VF events.

Main Results:

  • VLPs were detected in 35% of CAD patients, with higher prevalence in those with ventricular aneurysm (48%) or prior VT/VF (82%).
  • Patients with VLPs had a significantly higher incidence of sustained VT/VF (31% vs 2%) and mortality from VT/VF (p < 0.01).
  • VLP presence, length, and low ejection fraction were associated with increased arrhythmic risk.

Conclusions:

  • VLPs are prevalent in CAD and are a significant predictor of future sustained VT/VF.
  • VLP detection aids in risk stratification for sudden cardiac death in CAD patients.

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...